Zhan B. Zhang
Wenhua Road 103
Shenyang, 110016, China
Shenyang, 110016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Erratum to "A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+ CD24- enriched breast cancer stem-like cells" [Drug Resist. Updates 66 (2023) 100903].
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 05, 2025
Advances in Nanomedicine for Targeting Cancer Stem Cells and Overcoming Therapeutic Resistance.
Journal: ACS nano
Published: August 21, 2025
Radial Extracorporeal Shockwave Therapy Reduces Subchondral Osteoblast Senescence in Knee Osteoarthritis.
Journal: The American journal of sports medicine
Published: July 17, 2025
WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 07, 2025
From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapies.
Journal: Bioactive materials
Published: April 16, 2025
Erratum to: FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway.
Journal: Science China. Life sciences
Published: March 18, 2025
Role and Mechanism of Mechanical Load in the Homeostasis of the Subchondral Bone in Knee Osteoarthritis: A Comprehensive Review.
Journal: Journal of inflammation research
Published: September 03, 2024
Cartilage T2 mapping-based radiomics in knee osteoarthritis research: Status, progress and future outlook.
Journal: European journal of radiology
Published: August 05, 2024
Molecular classification of hormone receptor-positive /HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies.
Journal: Signal transduction and targeted therapy
Published: June 23, 2024
Polyphenol nanocomplex modulates lactate metabolic reprogramming and elicits immune responses to enhance cancer therapeutic effect.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: November 07, 2023
Last Updated: 09/26/2026